Suchergebnisse - "Calderón, Felix"

PubPharm (57)

1

Ending Malaria : Where Are We?

enthalten in: ACS infectious diseases | 2024

von Tavares, J. | Cordeiro-da-Silva, A. | Calderón, F.

2

Bromodomain factor 5 is an essential transcriptional regulator of the Leishmania genome

enthalten in: bioRxiv.org | 2024

von Jones, N. | Geoghegan, V. | Moore, G. | +9

3

Bromodomain Factor 5 as a Target for Antileishmanial Drug Discovery

enthalten in: bioRxiv.org | 2024

von Russell, C. | Carter, J. | Borgia, J. | +7

4

Identification of novel Bromodomain inhibitors ofTrypanosoma cruziBromodomain Factor 2 (TcBDF2) using a fluorescence polarization-base high-throughput assay

enthalten in: bioRxiv.org | 2024

von Serra, E. | Tavernelli, L. | Alonso, V. | +9

5

Bromodomain Factor 5 as a Target for Antileishmanial Drug Discovery

enthalten in: ACS infectious diseases | 2023

von Russell, C. | Carter, J. | Borgia, J. | +7

6

Tyrosine Kinase Inhibitors Display Potent Activity against Cryptosporidium parvum

enthalten in: Microbiology spectrum | 2023

von Nava, M. | Calderón, F. | Fernández, E. | +3

7

Essential bromodomain TcBDF2 as a drug target against Chagas disease

enthalten in: bioRxiv.org | 2022

von Pezza, A. | Tavernelli, L. | Alonso, V. | +9

8

Virtual Special Issue : Epigenetics 2022

enthalten in: ACS chemical biology | 2022

von Aldrich, C. | Calderón, F. | Conway, S. | +6

9

Virtual Special Issue : Epigenetics 2022

enthalten in: ACS infectious diseases | 2022

von Aldrich, C. | Calderón, F. | Conway, S. | +6

10

Virtual Special Issue : Epigenetics 2022

enthalten in: ACS pharmacology & translational science | 2022

von Aldrich, C. | Calderón, F. | Conway, S. | +6

1
2
3
4
5
6
Nächster »
[6]